Skip to content

Clinical trials

Phase 1 Esophageal Neoplasms trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Esophageal Neoplasms Phase: Phase 1 Country / region: Australia Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20171
20193
20201
20222
20233
20243
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Active, not recruiting4
Completed4
Recruiting3
Terminated3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company2
Pfizer2
Actym Therapeutics, Inc.1
Arcus Biosciences, Inc.1
BeiGene1
Genentech, Inc.1
Myeloid Therapeutics1
OncoC4, Inc.1
Quadriga Biosciences, Inc.1
Revolution Medicines, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Esophageal Neoplasms14
Stomach Neoplasms11
Ovarian Neoplasms10
Carcinoma, Non-Small-Cell Lung9
Colorectal Neoplasms9
Uterine Cervical Neoplasms9
Pancreatic Neoplasms7
Urinary Bladder Neoplasms7
Carcinoma, Renal Cell6
Squamous Cell Carcinoma of Head and Neck6

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.